Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)

Harmony Biosciences Holdings' Preferred Dividend Payments history spans 2 years, with the latest figure at $6.0 million for Q3 2020.

  • For Q3 2020, Preferred Dividend Payments changed N/A year-over-year to $6.0 million; the TTM value through Dec 2020 reached $26.9 million, changed N/A, while the annual FY2020 figure was $26.9 million, 23.64% down from the prior year.
  • Preferred Dividend Payments for Q3 2020 was $6.0 million at Harmony Biosciences Holdings, down from $10.4 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $10.4 million in Q2 2020 and bottomed at $6.0 million in Q3 2020.